Age (years) | 55.4±11.7 | 60±11.5 | 0.11 |
BMI (kg/m2) | 28.63±3.5 | 28.61±3.7 | 0.85 |
AF history (years) | 5.14±3.05 | 4.96±4.39) | 0.5 |
AF type LS-Ps | 7.4% | 24.2% | 0.16 |
Male sex (%) | 70.4% | 78.1% | 0.55 |
Hypertension | 54% | 75.9% | 0.14 |
Ischemic heart disease | 21.7% | 20.7% | 1 |
Heart failure | 50% | 34.8% | 0.5 |
Structural heart disease | 19.2% | 8.3% | 0.26 |
Dyslipidemia | 50% | 75% | 0.08 |
Type II diabetes | 34.8% | 20.7% | 0.34 |
Obstructive sleep apnea | 28.6% | 33.3% | 0.76 |
Smoking | 16.7% | 20% | 0.8 |
Atrial flutter | 77.3% | 55.6% | 0.14 |
PSVT associated | 5% | 7.1% | 0.79 |
CHA2DS2VASC score | 2.6±2 | 1.7±2.1 | 0.13 |
Cholesterol | 171.11±39.01 | 165.98±39.36 | 0.69 |
Triglycerides | 131.7±90.21 | 129.80±64.7 | 0.81 |
Serum creatinine level | 0.99±0.2 | 0.83±0.2 | 0.09 |
NTproBNP | 355.5±152.03 | 861.43±852.67 | 0.42 |
Serum hemoglobin | 12.13±2.6 | 14.19±0.9 | 0.11 |
P wave duration(ms) | 117.7±16.9 | 111±22.7 | 0.22 |
PR interval (ms) | 190.8±26.8 | 194.5±45.7 | 1 |
QRS duration (ms) | 95.5±17.5 | 93.8±20.9 | 0.53 |
cQT interval (ms) | 462.5±32.7 | 441.9±34.8 | 0.13 |
LA(ap diam, mm) | 45.7±4.5 | 42.7±7.8 | 0.04 |
LA area (cm2) | 24.11±4.01 | 23.09±4.16 | 0.66 |
LA (volume, ml/m2) | 44.69±11.9 | 47.27±6.88 | 0.88 |
RA (diam, mm) | 43.2±6.8 | 43±8.2 | 0.8 |
LVEF (%) | 54.87±6.14 | 49.96±10.59 | 0.09 |
Age (years) | 56.5±12.6 | 55.6±11 | 0.5 |
Weight (kg) | 89±16.6 | 84.8±15.1 | 0.66 |
BMI | 29.06±4.1 | 27.29±3.7 | 0.12 |
AF history (years) | 5.95±3.86 | 5.6±3.63 | 0.69 |
LS-Ps AF type (%) | 12.8% | 7.4% | 0.69 |
Males (%) | 73.7% | 85.2% | 0.36 |
Hypertension | 66.7% | 48% | 0.18 |
Ischemic heart disease | 24.3% | 12.5% | 0.33 |
Heart failure | 25.9% | 44.4% | 0.21 |
Dyslipidemia | 52.8% | 56% | 1 |
LDL cholesterol | 89.51±22.4 | 122.6±26.4 | 0.07 |
Type II diabetes | 22.2% | 19.2% | 1 |
GFR(MDRD) | 84.88±9.9 | 90.66±33 | 0.54 |
CHA2DS2Vasc | 2.5±1.7 | 1.2±2.2 | 0.04 |
Pw duration | 113.4±21.5 | 118±13.6 | 0.28 |
PR interval | 188.1±40.2 | 194.7±22 | 0.37 |
cQTi | 449.4±34.5 | 451.4±38 | 0.61 |
LA ap mm | 42.1±5.1 | 43.9±5.8 | 0.26 |
LA diam1 | 52.1±10.1 | 50±9 | 0.54 |
LA area (cm2) | 22.93±6.27 | 24.5±5.24 | 0.31 |
LA volume | 92.5±26.7 | 79.5±23.5 | 0.07 |
E/A | 2.03±0.65 | 1.75±0.7 | 0.4 |
TAPSE | 20.7±8.7 | 25.8±4.8 | 0.43 |
Intraprocedural oganization | 30.3% | 71.4% | 0.002 |
TT during RF delivery | 22.2% | 65.5% | 0.02 |
CFAE ablation | 71.9% | 69.2% | 1 |
Age | 54 ±11.6 | 55 ±11.5 | 0.9 |
BMI | 29.3 ±3.9 | 29 ±3.8 | 1 |
Pwave (ms) | 120 ±20 | 145 ±10 | 0.7 |
AF duration | 5.6 ±2.3 | 5.7 ±4.5 | 0.9 |
LA-d | 61 ±2.1 | 60.2 ±11.2 | 0.9 |
LA-area (cm2) | 31 ±2.8 | 24 ±2.9 | 0.07 |
LAAfw (m/s) | 0.5 ±0.57 | 0.36 ±0.13 | 0.2 |
AF term by ABLA | 37.5% | 45% | 1 |
Acute SR restoration | 93.4% |
CFAE ablation | 60% |
Lines/PWBI | 23% |
Atypical atrial flutter ablation | 20.5% |
Recurrence rate after first procedure | 65.2% |
Recurrence rate after all procedures | 41% |